Isoniazid + rifampin + pyrazinamide + ethambutol x 8wk followed by INH/rifampin x18wk
2 drug continuation treatment x 18-31wk
Use of pyrazinamide in pregnancy is controversial and typically reserved for women with MDR<unk> 
2 drug continuation treatment x 18-31wk
Use of pyrazinamide in pregnancy is controversial and typically reserved for women with MDR<unk> 
Isoniazid x 9 months
Consider treatment for:
Recent conversion to PPD-positive
close contact with active<unk> 
immunocompromised patients (or plan to start immunosuppressive medications)
New vaccine has demonstrated effectiveness (50%) in preventing progression to active<unk> . However, this is not yet widely available and further research is needed.
Recent conversion to PPD-positive
close contact with active<unk> 
immunocompromised patients (or plan to start immunosuppressive medications)
Tuberculosis
HIV neurologic complications
Aspergillosis
Toxoplasmosis
Sarcoidosis
Cryptococcosis
Histoplasmosis
AIDS Dementia